Christopher P. Filson

1.5k total citations
40 papers, 438 citations indexed

About

Christopher P. Filson is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Oncology. According to data from OpenAlex, Christopher P. Filson has authored 40 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in General Health Professions and 13 papers in Oncology. Recurrent topics in Christopher P. Filson's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (11 papers) and Global Cancer Incidence and Screening (8 papers). Christopher P. Filson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (11 papers) and Global Cancer Incidence and Screening (8 papers). Christopher P. Filson collaborates with scholars based in United States, Canada and Australia. Christopher P. Filson's co-authors include David H. Howard, Martin G. Sanda, Muta M. Issa, Dattatraya Patil, Yu Liu, Peter R. Carroll, Ingrid J. Hall, Wen Liu, Reneé H. Moore and Donna L. Berry and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Urology.

In The Last Decade

Christopher P. Filson

39 papers receiving 435 citations

Peers

Countries citing papers authored by Christopher P. Filson

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Filson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Filson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Filson more than expected).

Fields of papers citing papers by Christopher P. Filson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Filson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Filson. The network helps show where Christopher P. Filson may publish in the future.

Co-authorship network of co-authors of Christopher P. Filson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Filson. A scholar is included among the top collaborators of Christopher P. Filson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Filson. Christopher P. Filson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting 2024 ·European Urology Oncology ·Michael S. Leapman, (unknown), Yang Liu, Christopher P. Filson, (unknown), (unknown), J. Proudfoot, Elai Davicioni, Darryl T. Martin, Yi An, Tyler M. Seibert, Daniel W. Lin, Daniel E. Spratt, Matthew R. Cooperberg, Preston Sprenkle, Ashley E. Ross	2
2	Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage 2024 ·JAMA Network Open ·Michael Leapman, (unknown), Yang Liu, Christopher P. Filson, (unknown), (unknown), J. Proudfoot, Elai Davicioni, Darryl T. Martin, Yi An, Tyler M. Seibert, Daniel W. Lin, Daniel E. Spratt, Matthew R. Cooperberg, Ashley E. Ross, Preston Sprenkle	2
3	Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries 2023 ·Urologic Oncology Seminars and Original Investigations ·Parth K. Modi, Kevin C. Ward, Christopher P. Filson	4
4	Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance 2023 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Soohyun Hwang, Ramsankar Basak, (unknown), Christopher P. Filson, Bruce L. Jacobs, Hung‐Jui Tan	1
5	Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database 2021 ·Clinical Genitourinary Cancer ·Karen M. Xu, Yuan Liu, Theresa Gillespie, Adeboye O. Osunkoya, Bradley Curtis Carthon, Mehmet Asım Bilen, Christopher P. Filson, Kenneth Ogan, Pretesh Patel, Joseph W. Shelton, Ömer Küçük, Shreyas Joshi, Ashesh B. Jani	4
6	Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial 2021 ·Urologic Oncology Seminars and Original Investigations ·Donna L. Berry, Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Niya Xiong, Christopher P. Filson, Viraj A. Master, Martin G. Sanda, Peter Chang, Gary W. Chien, Randy Jones, Tracey L. Krupski, Seth Wolpin, Leslie Wilson, Julia H. Hayes, Quoc‐Dien Trinh, (unknown)	14
7	Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI 2021 ·Urologic Oncology Seminars and Original Investigations ·Jonathan Li, Dattatraya Patil, Martin G. Sanda, Christopher P. Filson	0
8	Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma 2020 ·Urology ·Dattatraya Patil, (unknown), (unknown), Mehrdad Alemozaffar, Aaron Lay, John Pattaras, Christopher P. Filson, Kenneth Ogan, Mehmet Asım Bilen, Viraj A. Master	4
9	Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer 2020 ·Urologic Oncology Seminars and Original Investigations ·Yu Liu, Ingrid J. Hall, Christopher P. Filson, David H. Howard	28
10	Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance 2019 ·European Urology Focus ·Liam C. Macleod, Jonathan G. Yabes, Mina Fam, Jathin Bandari, (unknown), Avinash Maganty, Alessandro Furlan, Christopher P. Filson, Benjamin J. Davies, Bruce L. Jacobs	4
11	Use of Office Versus Ambulatory Surgery Center Setting and Associated Ancillary Services on Healthcare Cost Burden for Vasectomy Procedures 2019 ·Urology ·(unknown), Amir Ishaq Khan, Dattatraya Patil, Christopher P. Filson, Akanksha Mehta	5
12	In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI 2019 ·Radiology Imaging Cancer ·(unknown), Christopher P. Filson, Martin G. Sanda, Adeboye O. Osunkoya, Sherif G. Nour	1
13	Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance. 2019 ·Journal of Clinical Oncology ·Avinash Maganty, (unknown), Liam C. Macleod, Jonathan G. Yabes, Mina Fam, Jathin Bandari, Robert Turner, Alessandro Furlan, Christopher P. Filson, Benjamin J. Davies, Bruce L. Jacobs	1
14	African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study 2019 ·The Journal of Urology ·Jeannette M. Schenk, Lisa F. Newcomb, Yingye Zheng, Anna Faino, Kehao Zhu, Yaw A. Nyame, James D. Brooks, Peter R. Carroll, Matthew R. Cooperberg, Atreya Dash, Christopher P. Filson, Martin Gleave, Michael A. Liss, Francis Martin, Todd M. Morgan, Peter S. Nelson, Ian M. Thompson, Andrew A. Wagner, Daniel W. Lin	25
15	Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States 2018 ·Urology ·Wen Liu, Dattatraya Patil, David H. Howard, Reneé H. Moore, Heqiong Wang, Martin G. Sanda, Christopher P. Filson	42
16	Quality of care and economic considerations of active surveillance of men with prostate cancer 2018 ·Translational Andrology and Urology ·Christopher P. Filson	4
17	Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure 2017 ·Nature Reviews Urology ·Sophie Bruinsma, Monique J. Roobol, Peter R. Carroll, Laurence Klotz, Tom Pickles, Caroline M. Moore, Vincent J. Gnanapragasam, Arnauld Villers, Antti Rannikko, R. Valdagni, Mark Frydenberg, Yoshiyuki Kakehi, Christopher P. Filson, Chris H. Bangma	49
18	Patient Acceptance of Teleurology via Telephone vs Face-to-Face Clinic Visits for Hematuria Consultation at a Veterans Affairs Medical Center 2017 ·Urology Practice ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christopher P. Filson, Muta M. Issa	8
19	A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma 2017 ·Asian journal of urology ·(unknown), Dattatraya Patil, (unknown), Jeffrey Pearl, (unknown), Mehmet Asım Bilen, Ömer Küçük, Wayne Harris, Bradley Curtis Carthon, Mehrdad Alemozaffar, Christopher P. Filson, John Pattaras, Peter T. Nieh, Kenneth Ogan, Viraj A. Master	13
20	Implementation of a Tele-urology Program for Outpatient Hematuria Referrals: Initial Results and Patient Satisfaction 2016 ·Urology ·(unknown), (unknown), Samuel David, Jonathan Huang, (unknown), Jeffrey Pearl, (unknown), James R. Baumgardner, Christopher P. Filson, Muta M. Issa	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact